535 related articles for article (PubMed ID: 15732748)
1. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
Lambert LA; Ijaz K; Navin TR
Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
[No Abstract] [Full Text] [Related]
2. Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
Lincoln T; Brannan GL; Lynch V; Conklin TJ; Clancey T; Rose DN; Tuthill RJ
Int J Tuberc Lung Dis; 2004 Mar; 8(3):306-11. PubMed ID: 15139468
[TBL] [Abstract][Full Text] [Related]
3. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG; Lötter AP
Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
[No Abstract] [Full Text] [Related]
4. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic tuberculosis: a case with pseudotumours form].
Sève P; Boibieux A; Biron F; Bouhour D; Rode A; Bancel B; Chidiac C; Peyramond D
Ann Med Interne (Paris); 1998 Oct; 149(6):386-8. PubMed ID: 9853049
[No Abstract] [Full Text] [Related]
6. Is the recommendation not to use rifampin plus pyrazinamide for latent tuberculosis treatment always imperative?
Cazzadori A; Allegranzi B; Scardigli A; Favari F; Concia E
Chest; 2004 Aug; 126(2):657-8. PubMed ID: 15302765
[No Abstract] [Full Text] [Related]
7. [Short-course chemotherapy of tuberculosis with pyrazinamide].
Asai S; Futsuki Y; Tomari S; Araki J
Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
[TBL] [Abstract][Full Text] [Related]
8. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
9. [Our experience in short-course treatment of tuberculosis. Results obtained by using therapeutic regimens of 6 to 8 months].
Ben Kheder A; Chabbou A; Zakhama B; Zaimi M; el Gharbi T; el Mekki L; el Gharbi B
Bull Int Union Tuberc; 1985; 60(1-2):26-8. PubMed ID: 4074968
[No Abstract] [Full Text] [Related]
10. Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.
Martínez E; Collazos J; Mayo J
Clin Infect Dis; 1998 Nov; 27(5):1329-30. PubMed ID: 9827298
[No Abstract] [Full Text] [Related]
11. Modern treatment of tuberculosis.
Dutt AK; Stead WW
Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
[No Abstract] [Full Text] [Related]
12. Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis.
Rose DN
Ann Intern Med; 1998 Nov; 129(10):779-86. PubMed ID: 9841583
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Danckwerts MP; Ebrahim S; Pillay V
Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
[TBL] [Abstract][Full Text] [Related]
14. [Primary tuberculosis of the oral cavity].
Junquera Gutiérrez LM; Alonso Vaquero D; Albertos Castro JM; Palacios Gutierrez JJ; Vicente Rodriguez JC
Rev Stomatol Chir Maxillofac; 1996; 97(1):3-6. PubMed ID: 8628965
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis treatment: dangerous regimens?
Rieder HL; Arnadottir T; Trébucq A; Enarson DA
Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
[No Abstract] [Full Text] [Related]
16. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
Brändli O; Dreher D; Morger D
Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
[TBL] [Abstract][Full Text] [Related]
17. Granulomatous lesion on the face successfully treated with antitubercular therapy.
Ricart JM; Martín JM; Renau A; Pérez J
Dermatol Online J; 2010 Sep; 16(9):13. PubMed ID: 20875334
[No Abstract] [Full Text] [Related]
18. [Current state of the short-course chemotherapy. Apropos of the International Round Table in Florence].
Larbaoui D
Bull Int Union Tuberc; 1985; 60(1-2):18-25. PubMed ID: 4074967
[No Abstract] [Full Text] [Related]
19. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
Jasmer RM; Saukkonen JJ; Blumberg HM; Daley CL; Bernardo J; Vittinghoff E; King MD; Kawamura LM; Hopewell PC;
Ann Intern Med; 2002 Oct; 137(8):640-7. PubMed ID: 12379063
[TBL] [Abstract][Full Text] [Related]
20. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Pretet S; Grosset J; Perdrizet S
Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
